Interleukin-10: A Key Cytokine in Depression?
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
An increasing body of evidence implicates proinflammatory cytokines in psychiatric disorders, namely, in depression. Of notice, recent studies showed that anti-inflammatory cytokines, such as IL-10, also modulate depressive-like behavior. In this article, we propose that the anti-inflammatory cytokine IL-10 is a putative link between two of the most widely reported phenomenon observed in depressed patients: the disruption of the hypothalamic-pituitary-adrenal axis and the imbalanced production of cytokines. If so, IL-10 might represent a novel target for antidepressant therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“IL-10 knockout mice showed learned helplessness in animal depression models, a symptom that could be reverted by application of IL-10, whereas IL-10 administration led to increased motor activity in wild-type mice.”
From Selected biomarkers of depression: what are the effects of cytokines and inflammation (2022) · cites this paper as [109]
In the citing paper
“Yet the literature also yields studies that report increased IL-10 levels in MDD.”
From Selected biomarkers of depression: what are the effects of cytokines and inflammation (2022) · cites this paper as [109]
In the citing paper
“Decreased levels of IL-10 were described in humans with symptoms of depression, anxiety, and increased suicide risk in a population study, as well as in stroke patients who developed the depressive disorder.”
From Selected biomarkers of depression: what are the effects of cytokines and inflammation (2022) · cites this paper as [109]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395 · cited 1×
“Research using these models demonstrated that alteration in the proinflammatory cytokine milieu can lead to behavioral changes overlapping with those found in depressed patients, including anhedonia, decreased activity, cognitive dysfunction, and altered sleep patterns [12].”
BackgroundInterleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737
Depression, chronic diseases, and decrements in health: results from the World Health Surveys
Moussavi, S., Chatterji, S., Verdes, E., Tandon, A., Patel, V., & Ustun, B. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61415-9 · Cited by 4,070 · cited 1×
“Major depression is a global public-health problem and a leading cause of disability worldwide, representing the fourth contributor to the global burden of disease in 2000 (in terms of DALYs-Disability Adjusted Life Years) [3].”
BackgroundDepression and Pain Comorbidity: A Literature Review
Bair, M. J., Robinson, R. L., Katon, W., & Kroenke, K. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.20.2433 · Cited by 3,463 · cited 1×
“Another feature commonly associated with depression is altered pain perception [20].”
BackgroundCytokines sing the blues: inflammation and the pathogenesis of depression
Raison, C. L., Capuron, L., & Miller, A. H. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.11.006 · Cited by 3,009 · cited 1×
“It is possible that IL-10, like other cytokines, acts directly in the brain through regions devoided of blood-brain barrier, such as the circumventricular organs and the choroid plexus, or by activating vagal afferent fibers that can transmit cytokine signals to specific brain nuclei [5].”
BackgroundBelmaker, R. H., & Agam, G. (2008) · New England Journal of Medicine · doi:10.1056/nejmra073096 · Cited by 2,166
Regulation of the Hypothalamic-Pituitary-Adrenal Axis by Cytokines: Actions and Mechanisms of Action
TURNBULL, A. V., & RIVIER, C. L. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.1.1 · Cited by 1,297 · cited 1×
“Paradoxically, in the hypothalamus and pituitary, IL-10 seems to have the same effect already described for some proinflammatory cytokines [45], which is a positive regulation of corticotrophin releasing factor (CRF) and ACTH production, respectively [43, 46].”
BackgroundRaison, C. L., & Miller, A. H. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.9.1554 · Cited by 1,197
Barrat, F. J., Cua, D. J., Boonstra, A., Richards, D. F., Crain, C., Savelkoul, H. F., de Waal-Malefyt, R., Coffman, R. L., Hawrylowicz, C. M., & O'Garra, A. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011629 · Cited by 1,161
Paroxetine for the prevention of depression induced by high-dose interferon alfa.
Musselman, D. L., Lawson, D. H., Gumnick, J. F., Manatunga, A. K., Penna, S., Goodkin, R. S., Greiner, K., Nemeroff, C. B., & Miller, A. H. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103293441303 · Cited by 1,120
Cited by
Selected biomarkers of depression: what are the effects of cytokines and inflammation
Harsanyi, S., Kupcova, I., Danisovic, L., & Klein, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010578 · Cited by 299
Hiles, S. A., Baker, A. L., de Malmanche, T., & Attia, J. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.06.001 · Cited by 274
“IL-10 is also elevated in response to acute immune challenge (Henry et al., 2009) and may be implicated in depression (Mesquita et al., 2008; Roque et al., 2009).”
BackgroundVoorhees, J. L., Tarr, A. J., Wohleb, E. S., Godbout, J. P., Mo, X., Sheridan, J. F., Eubank, T. D., & Marsh, C. B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058488 · Cited by 236
Ohgi, Y., Futamura, T., Kikuchi, T., & Hashimoto, K. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.12.003 · Cited by 207
“IL-10 is a key regulator of depression symptoms (Roque et al., 2009).”
Martin-Subero, M., Anderson, G., Kanchanatawan, B., Berk, M., & Maes, M. (2016) · CNS Spectrums · doi:10.1017/s1092852915000449 · Cited by 196
The effects of vitamin B on the immune/cytokine network and their involvement in depression
Mikkelsen, K., Stojanovska, L., Prakash, M. D., & Apostolopoulos, V. (2016) · Maturitas · doi:10.1016/j.maturitas.2016.11.012 · Cited by 169
Morris, G., Anderson, G., & Maes, M. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-0170-2 · Cited by 121
“ticosterone concentrations as compared with IL-10+/+ wildtype mice, suggesting that IL-10 negatively regulates GC synthesis [105].”
BackgroundInfluentialKubera, M., Curzytek, K., Duda, W., Leskiewicz, M., Basta-Kaim, A., Budziszewska, B., Roman, A., Zajicova, A., Holan, V., Szczesny, E., et al. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2013.01.001 · Cited by 113
“In this regard, a recent review hypothesized that IL-10 may be a key factor in clinical depression (Roque et al., 2009).”
BackgroundEuteneuer, F., Dannehl, K., del Rey, A., Engler, H., Schedlowski, M., & Rief, W. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.76 · Cited by 107
Medina-Rodriguez, E. M., Lowell, J. A., Worthen, R. J., Syed, S. A., & Beurel, E. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00547 · Cited by 101
“, 2000), whereas desipramine, increases IL-10 in MDD patients but does not affect pro-inflammatory cytokines (Roque et al., 2009).”
BackgroundTaraz, M., Taraz, S., & Dashti‐Khavidaki, S. (2014) · Hemodialysis International · doi:10.1111/hdi.12200 · Cited by 104
Depression as an evolutionary strategy for defense against infection
Anders, S. L., Tanaka, M., & Kinney, D. K. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.12.002 · Cited by 92
“…cite this article in press as: Anders, S., et al. Depression as an evolutionary dx.doi.org/10.1016/j.bbi.2012.12.002 with laboratory animals there is evidence that IL-10 modulates numerous features associated with depression including sleep, helplessness, and pain perception (Roque et al., 2009).”
BackgroundInfluentialSauna use as a lifestyle practice to extend healthspan
Patrick, R. P., & Johnson, T. L. (2021) · Experimental Gerontology · doi:10.1016/j.exger.2021.111509 · Cited by 88
Contributions of animal models to the study of mood disorders
Valvassori, S. S., Budni, J., Varela, R. B., & Quevedo, J. (2013) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2013-1168 · Cited by 82
Anjum, S., Qusar, M. M. A. S., Shahriar, M., Islam, S. M. A., Bhuiyan, M. A., & Islam, M. R. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320916655 · Cited by 70
Xie, Z.-M., Wang, X.-M., Xu, N., Wang, J., Pan, W., Tang, X.-H., Zhou, Z.-Q., Hashimoto, K., & Yang, J.-J. (2017) · Scientific Reports · doi:10.1038/s41598-017-03590-3 · Cited by 71
IL-4/10 prevents stress vulnerability following imipramine discontinuation
Han, A., Yeo, H., Park, M.-J., Kim, S. H., Choi, H. J., Hong, C.-W., & Kwon, M.-S. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0416-3 · Cited by 60
“Previous studies have suggested that anti-inflammatory cytokines affect depressive behavior as a failure to counterbalance the increased expression of pro-inflammatory cytokines [12, 13].”
BackgroundA Study of TNF-α, TGF-β, IL-10, IL-6, and IFN-γ Gene Polymorphisms in Patients with Depression
Mihailova, S., Ivanova-Genova, E., Lukanov, T., Stoyanova, V., Milanova, V., & Naumova, E. (2016) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2016.03.005 · Cited by 61
Euteneuer, F., Dannehl, K., del Rey, A., Engler, H., Schedlowski, M., & Rief, W. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00250 · Cited by 57
Haastrup, E. K., Bukh, J. D., Bock, C., Vinberg, M., Thørner, L. W., Hansen, T. F., Werge, T. M., Kessing, L. V., & Ullum, H. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.08.025 · Cited by 58
Probiotic ‘glow of health’: it's more than skin deep
Erdman, S. E., & Poutahidis, T. (2014) · Beneficial Microbes · doi:10.3920/bm2013.0042 · Cited by 56
“In addition to immune tolerance, anti-inflammatory IL-10 has also been implicated either directly or indirectly in regulation of hypothalamic-pituitary-adrenal (HPA) axis hormones, impacting diverse aspects of physiology, attitude, and behaviour (Roque et al., 2009; Smith et al., 1999).”
BackgroundInfluentialLabaka, A., Gómez-Lázaro, E., Vegas, Ó., Pérez-Tejada, J., Arregi, A., & Garmendia, L. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.08.002 · Cited by 55
Alberti, A., Coelho, D. R. A., Vieira, W. F., Iser, B. P. M., Lampert, R., Traebert, E., da Silva, B. B., de Oliveira, B. H., Leão, G. M., de Souza, G., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12091994 · Cited by 55
“…suggesting that The mechanisms investigation stress in with females Increased to the brain can exhibit pro-resolving cells can differentiate in response to the microenvironment, releasing specific mediators that contribute to neuroin-flammation and the progression of depression [157,159–161].”
BackgroundWang, Q., Dong, X., Wang, Y., Liu, M., Sun, A., Li, N., lin, Y., Geng, Z., Jin, Y., & Li, X. (2017) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2017.07.007 · Cited by 46
“Early maternal separation (MS) mimics early life neglect/ loss of parents in humans and is one of the stressors to which rat pups can be exposed (Rosenfeld et al., 1992).”
BackgroundCasaril, A. M., Domingues, M., Bampi, S. R., Lourenço, D. D. A., Smaniotto, T. Â., Segatto, N. V., Vieira, B. M., Seixas, F. K., Collares, T. V., Lenardao, E. J., et al. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.12.005 · Cited by 49
Barua, C. C., Haloi, P., Saikia, B., Sulakhiya, K., Pathak, D. C., Tamuli, S., Rizavi, H., & Ren, X. (2018) · Pharmaceutical Biology · doi:10.1080/13880209.2017.1391298 · Cited by 51
“In addition, the anti-inflammatory cytokine, IL-10 ameliorates LPS-induced sickness behaviour and depressive symptoms in transgenic mice (Harvey et al. 2006; Mesquita et al. 2008; Roque et al. 2009).”
BackgroundIntegrating the monoamine and cytokine hypotheses of depression: Is histamine the missing link?
Hersey, M., Hashemi, P., & Reagan, L. P. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15392 · Cited by 46
“IL-10 has also been linked to depressive-like behaviours and to decreased HPA axis reactivity (Mesquita et al., 2008; Roque et al., 2009).”
BackgroundDepressive symptoms and inflammation in patients hospitalized for heart failure
Johansson, P., Lesman‐Leegte, I., Svensson, E., Voors, A. A., van Veldhuisen, D. J., & Jaarsma, T. (2011) · American Heart Journal · doi:10.1016/j.ahj.2011.03.011 · Cited by 41
Antidepressant Effect of Intermittent Long-Term Systemic Administration of Irisin in Mice
Pignataro, P., Dicarlo, M., Zerlotin, R., Storlino, G., Oranger, A., Sanesi, L., Lovero, R., Buccoliero, C., Mori, G., Colaianni, G., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147596 · Cited by 45
Hennessy, M. B., Chun, K., & Capitanio, J. P. (2016) · Social Neuroscience · doi:10.1080/17470919.2016.1145595 · Cited by 42
“Mean seconds from initiation of disturbance until blood collection at the various time points were as follows: field cage—521 s, day 1—508 s, day 3 —492 s, and day 8—637 s. Baseline and stimulated cytokine levels For IL-10, ANOVA yielded a significant main effect of Baseline/LPS, F (1, 19) = 112.38, p < 0.001, with a…”
BackgroundInfluentialXia, J., Wang, H., Zhang, C., Liu, B., Li, Y., Li, K., Li, P., & Song, C. (2023) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2022.1059594 · Cited by 40
Chen, L., Wang, X., Zhang, Y., Zhong, H., Wang, C., Gao, P., & Li, B. (2021) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2021.671864 · Cited by 40
“Meanwhile, antidepressants have been shown to suppress the production of pro-inflammatory cytokines (Mutlu et al., 2012) while stimulating the production of interleukin (IL)10, an anti-inflammatory cytokine (Roque et al., 2009).”
BackgroundDantas, R. L., Freff, J., Ambrée, O., Beins, E. C., Forstner, A. J., Dannlowski, U., Baune, B. T., Scheu, S., & Alferink, J. (2021) · Cells · doi:10.3390/cells10040941 · Cited by 32
“For example, IL-10 knockout mice show increased depression-like behavior and administration of IL-10 rescued depression-associated learning and memory deficits in mice [74,75].”
BackgroundLalitsuradej, E., Sirilun, S., Sittiprapaporn, P., Sivamaruthi, B. S., Pintha, K., Tantipaiboonwong, P., Khongtan, S., Fukngoen, P., Peerajan, S., & Chaiyasut, C. (2022) · Foods · doi:10.3390/foods11050759 · Cited by 30
Hsu, J.-W., Lirng, J., Wang, S., Lin, C.-L., Yang, K., Liao, M., & Chou, Y. H. (2013) · Bipolar Disorders · doi:10.1111/bdi.12164 · Cited by 32
“The role of IL-10 in BD is still ambiguous, although it has been suggested to be relevant to depression (38, 39).”
BackgroundPotential antianxiety activity of Fumaria indica: A preclinical study
Kumar, V., Chatterjee, S., Singh, G. K., Chauhan, S. K., & Rai, G. (2013) · Pharmacognosy Magazine · doi:10.4103/0973-1296.108129 · Cited by 31
Goodkin, K., Evering, T. H., Anderson, A. M. L., Ragin, A. B., Monaco, C. L., Gavegnano, C., Avery, R. J., Rourke, S. B., Cysique, L. A., & Brew, B. J. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1130938 · Cited by 27
Meyer, T., Stanske, B., Kochen, M. M., Cordes, A., Yüksel, I., Wachter, R., Lüers, C., Scherer, M., Binder, L., Pieske, B. M., et al. (2011) · Behavioral Medicine · doi:10.1080/08964289.2011.609192 · Cited by 27
Zuelli, F. M. D. G. C., Fachim, H., Loureiro, C. M., Shuhama, R., Bertozi, G., Joca, S. R. L., Menezes, P. R., Louzada‐Júnior, P., & Del‐Ben, C. M. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.01011 · Cited by 26
Associations between childhood maltreatment and inflammatory markers
Palmos, A., Watson, S., Hughes, T. E., Finkelmeyer, A. E., McAllister-Williams, H., Ferrier, N., Anderson, I. M., Nair, R., Young, A. H., Strawbridge, R., et al. (2019) · BJPsych Open · doi:10.1192/bjo.2018.80 · Cited by 26
Chou, Y.-H., Hsieh, W.-C., Chen, L.-C., Lirng, J.-F., & Wang, S.-J. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.10.056 · Cited by 23
“Although it has been suggested to be relevant in depression, the role of IL-10 in BD is still ambiguous (Maes, 1993; Roque et al., 2009).”
BackgroundRuiz-Pablos, M., Paiva, B., & Zabaleta, A. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04515-7 · Cited by 25
Kostadinov, I., Delev, D. P., Petrova, A., Stanimirova, I., Draganova, K., Kostadinova, I. I., & Murdjeva, M. (2014) · Biotechnology & Biotechnological Equipment · doi:10.1080/13102818.2014.932136 · Cited by 25
Duda, W., Kubera, M., Kreiner, G., Curzytek, K., Detka, J., Głombik, K., Ślusarczyk, J., Basta‐Kaim, A., Budziszewska, B., Lasoń, W., et al. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.04.021 · Cited by 22
“IL-10 plays an important role in the regulation of depression symptoms [59].”
BackgroundKhoury, R. E., & Nagy, C. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1154872 · Cited by 22
“(2022) Some studies have shown that individuals with depression may have lower levels of IL-10, suggesting that reduced anti-inflammatory activity could be involved in the development of depressive symptoms (Roque et al., 2009).”
BackgroundRoque, S., Oliveira, T. G., Nóbrega, C., Barreira‐Silva, P., Nunes-Alves, C., Sousa, N., Palha, J. A., & Correia‐Neves, M. (2011) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2011.00004 · Cited by 20
Self-citationPerna, L., Trares, K., Perneczky, R., Tatò, M., Stocker, H. R., Möllers, T., Holleczek, B., Schöttker, B., & Brenner, H. (2021) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2021.12.001 · Cited by 20
Ardakani, M. T., Mehrpooya, M., Mehdizadeh, M., Hajifathali, A., & Abdolahi, A. (2015) · PubMed Central · Cited by 22
Yu, W. S., Kwon, S., Agadagba, S. K., Chan, L.-L.-H., Wong, K.-H., & Lim, L. W. (2021) · Cells · doi:10.3390/cells10092492 · Cited by 18
“Moreover, ECT was also reported to increase the level of blood IL-10 [115], which is a well-established anti-inflammatory cytokine that prevents neuronal and glial cell death [128].”
BackgroundFerrari, S., Mulè, S., Rosso, G., Parini, F., Galla, R., Molinari, C. G., & Uberti, F. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25094774 · Cited by 16
“IL-10 IL-10 impacts several symptoms associated with depression, namely, helplessness, sleep disturbances, and pain perception [45,47].”
BackgroundHoprekstad, G. E., Kjelby, E., Gjestad, R., Fathian, F., Larsen, T. K., Reitan, S. K., Rettenbacher, M. A., Torsvik, A., Skrede, S., Johnsen, E., et al. (2023) · Schizophrenia Research · doi:10.1016/j.schres.2022.12.049 · Cited by 14
Kiropoulos, L. A., Rozenblat, V., & Baes, N. (2024) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2024.100939 · Cited by 16
“…suggested that IL-10 levels increase initially in response to acute inflammation as part of the immune system response connected with depression with IL-10 levels eventually decreasing over the course of depression (Wiener et al., 2019; Chi et al., 2021; Al-Fadhel et al., 2019; Roque et al., 2009).”
Nass, S. R., Hahn, Y. K., Ohene‐Nyako, M., McLane, V. D., Damaj, M. I., Thacker, L. R., Knapp, P. E., & Hauser, K. F. (2023) · Viruses · doi:10.3390/v15030590 · Cited by 12
Wrona, D., Listowska, M., Kubera, M., Glac, W., Grembecka, B., Plucińska, K., Majkutewicz, I., & Podlacha, M. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.10.001 · Cited by 12
“It has also been reported that IL-10 may have a regulatory effect on the hypothalamic–pituitary–adrenal (HPA) axis (Roque et al., 2009) and exerts a negative regulation on corticosterone production by the adrenal gland (Koldzic-Zivanovic et al.”
BackgroundYama, K., Asari, Y., Ono, A., Machida, M., & Miura, J. (2020) · Women s Health Reports · doi:10.1089/whr.2019.0010 · Cited by 11
“reported that IL-10 levels are related to depression.(37) Therefore, inflammation might underlie the pathogeneses of PMS and major depressive disorder.”
BackgroundStröher, R., de Oliveira, C., Stein, D. J., de Macedo, I. C., Goularte, J. F., da Silva, L. S., Regner, G. G., Medeiros, H. R., Caumo, W., & Torres, I. L. D. S. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2019.12.027 · Cited by 11
Ruiz-Pablos, M., Paiva, B., & Zabaleta, A. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1422940 · Cited by 9
Qiao, Y., Li, C., Zhang, M., Zhang, X., Wei, L., Cao, K., Zhang, X., Bi, H., & Gao, T. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.971243 · Cited by 9
“The hippocampus plays a crucial role in learning and memory, and changes in hippocampal volume are associated with cognitive deficits in major depression (Bremner et al., 2000; Sahay and Hen, 2007; Chen et al., 2015).”
BackgroundYing, Z., Huang, Y., Shao, M., Chi, C., Jiang, M., Chen, Y., Yuchen, Sun, M.-X., Zhu, Y.-Y., & Li, X. (2023) · Journal of Clinical Neurology · doi:10.3988/jcn.2022.0151 · Cited by 8
Mandal, S., Spoorthy, M. S., Godi, S. M., Nanda, R., Mukherjee, B., & Mishra, N. R. (2023) · Cureus · doi:10.7759/cureus.43059 · Cited by 8
“[5,16] The antiinflammatory marker IL-10 levels in this study were not significantly different between baseline and posttreatment levels at eight weeks of follow-up.”
BackgroundStudy on anti-inflammatory and immunomodulatory effects of fluoxetine in rat models of inflammation
Kostadinov, I., Delev, D. P., Petrova, A., Stanimirova, I., Draganova, K., Kružliak, P., Kostadinova, I. I., & Murdjeva, M. (2015) · European Journal of Inflammation · doi:10.1177/1721727x15618671 · Cited by 8
Knudsen, J. K., Bundgaard‐Nielsen, C., Leutscher, P., Hjerrild, S., Nielsen, R. E., & Sørensen, S. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-05547-z · Cited by 8
“As LBP was also negatively correlated with the anti-inflammatory IL-10, which has previously been found decreased in patients with MDD [94], this suggests that the gut microbiota confers a pro-inflammatory profile in patients with MDD.”
Ferizović, H., Spasojević, N., Stefanović, B., Janković, M., & Dronjak, S. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106615 · Cited by 6
Ecke, L. E., Cleck, J. N., White, P., Schug, J., Mifflin, L., & Blendy, J. A. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710001392 · Cited by 7
“Furthermore, the cytokine theory of depression suggests that enhanced production of pro-inflammatory cytokines is associated with the pathogenesis of depression (Roque et al. 2009).”
Wrona, D., Listowska, M., Kubera, M., Majkutewicz, I., Glac, W., Wojtyła-Kuchta, B., Plucińska, K., Grembecka, B., & Podlacha, M. (2013) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2013.10.002 · Cited by 6
Mikheeva, I. B., Malkov, A., Pavlik, L. L., Arkhipov, V. I., & Levin, S. G. (2019) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-019-04459-3 · Cited by 4
Systemic and Local Cytokines Profile Determine Severity and Prognosis in Human Septic Arthritis
González-Chapa, J. A., Peña‐Martínez, V. M., Vílchez-Cavazos, J. F., Salinas-Carmona, M. C., & Rosas-Taraco, A. G. (2021) · Archives of Medical Research · doi:10.1016/j.arcmed.2021.10.004 · Cited by 4
Schreiner, G. E., Schmitt, E. G., Brites, G. E., dos Santos, L. S., Maders, L. T., Gonçalves, I. L., Sarmento, S. M. D. M., Dartora, N., & Manfredini, V. (2024) · BioChem · doi:10.3390/biochem4030013 · Cited by 3
The Impact of Inflammation on Brain Function and Behavior in Rodent Models of Affective Disorders
Farzana, F., Renoir, T., & Hannan, A. J. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811073-7.00005-2 · Cited by 5
Husain, M. M., Guajardo, H. M., & Hubregsen, J. J. (2021) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2021.09.015 · Cited by 3
Iyer, S., Cao, Y., Liebegott, R., Chen, J., Ragab, A. A. Y., Doyle, M. F., Lunetta, K. L., & Murabito, J. M. (2025) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2025.107716 · Cited by 2
“These 10 proteins are IFN-gamma, IL-17C, IL10, IL6, IL8, CXCL5, FGF-19, MCP-1, TNFa, and VEGFa.”
InfluentialHarvey, A. K., Lelos, M. J., Greenhill, C., Jones, A. T., Clinch, S. P., Newton, M. J., Dunnett, S. B., Wyatt, S. L., Williams, A. S., & Jones, S. A. (2016) · Journal of Rheumatic Diseases and Treatment · doi:10.23937/2469-5726/1510033 · Cited by 2
PSYCHOBIOTICS; A NEW FRONTIER IN TREATMENT OF DEPRESSION
Bosco, A. M., Mishra, B., & Sojan, C. (2023) · International Journal of Pharmaceutics and Drug Analysis · doi:10.47957/ijpda.v11i1.534 · Cited by 2
Gonçalves, S. C. A., Gregório, J. F., Ferraz, K. S., Magalhães, G. S., Zebral, S. A., Fontes, M. A. P., Rodrigues‐Machado, M. D. G., Sinisterra, R. D., Haibara, A. S., Kangussu, L. M., et al. (2025) · Behavioural Brain Research · doi:10.1016/j.bbr.2025.115744 · Cited by 2
Sahraei, Z., Eshraghi, A., Eslami, N., & Mehdizadeh, M. (2015) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000000192 · Cited by 3
“Other studies have demonstrated that IL-10 is a key cytokine in depression, and its expression is possibly associated with an increased risk of depression.(15,16) Based on various studies, higher IL-18 level is associated with an increased susceptibility of patients to depression.”
BackgroundAsariati, H., Subandiyah, K., & Fitri, L. E. (2014) · Journal of Tropical Life Science · doi:10.11594/jtls.04.03.02 · Cited by 2
Hwang, W., Bae, J.-H., & Yeom, S. (2016) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2016.1214556 · Cited by 2
Aryaningrum, E., Salim, E. M., Apriansyah, M. A., Bahar, E., & Kusnadi, Y. (2021) · SRIWIJAYA JOURNAL OF MEDICINE · doi:10.32539/sjm.v4i3.117 · Cited by 2
Lorkiewicz, P., Adamczuk, J., Kryńska, J. A., Maciejczyk, M., Żendzian‐Piotrowska, M., Flisiak, R., Moniuszko-Malinowska, A. M., & Waszkiewicz, N. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27041670 · Cited by 1
BMP-7 links delayed memory impairment to severity of anhedonia in depression: A mediation model
Yuan, S., Jing, P., Zhang, X., Chen, P., Tian, Q., Sun, C., Zhang, G., Zhang, X., & Sun, W. (2026) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2026.111812 · Cited by 1
Gut Microbiome Production and Modulation of Hormones That Influence Host Skin HealthPreprint
Maguire, M., & Maguire, G. (2020) · Preprints.org · doi:10.20944/preprints202003.0293.v1 · Cited by 1
“oxytocin - both indirectly and directly (Roque et al., 2009).”
Bromander, S. (2013) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Echeverría, A. L. (2018) · Communities in ADDI (Universidad del Pais Vasco)
Early-life stress and inflammatory cytokines in psychoses: from bench to community-based research
Zuelli, F. M. D. G. C. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2020.tde-26072019-154034
(2017) · مجلة دراسات الطفولة · doi:10.21608/jsc.2017.93206
Restrepo, J. E., Zapata, W., Ossa-Giraldo, A. C., & Montoya, G. P. C. (2022) · Informes Psicológicos · doi:10.18566/infpsic.v22n2a04
von Knebel, K. A. (2022) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-9504
Altered serum cytokines in patients with symptomatic disk herniation and depressive symptoms
Bielewicz, J., Daniluk, B., & Kamieniak, P. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1366559 · Cited by 1
Kurnianingsih, N., Rahma, O. A., Prayogo, N. P., Rayhanna, Q. A., Fahanani, A. F., Suprapto, R. P., Prakosa, A. G., & Ratnawati, R. (2024) · Pharmaceutical Sciences and Research · doi:10.7454/psr.v11i3.1363
Neuropsychiatric Disorders and Their Relations to Host Immunological PathwaysPreprint
Hu, W. (2025) · Preprints.org · doi:10.20944/preprints202509.2232.v1
Knudsen, J. K., Bundgaard‐Nielsen, C., Leutscher, P., Hjerrild, S., Nielsen, R. E., & Sørensen, S. (2024) · Figshare · doi:10.6084/m9.figshare.25123989
Knudsen, J. K., Bundgaard‐Nielsen, C., Leutscher, P., Hjerrild, S., Nielsen, R. E., & Sørensen, S. (2024) · VBN Forskningsportal (Aalborg Universitet) · doi:10.6084/m9.figshare.26675216
Knudsen, J. K., Bundgaard‐Nielsen, C., Leutscher, P., Hjerrild, S., Nielsen, R. E., & Sørensen, S. (2024) · VBN Forskningsportal (Aalborg Universitet) · doi:10.6084/m9.figshare.26675225
Knudsen, J. K., Bundgaard‐Nielsen, C., Leutscher, P., Hjerrild, S., Nielsen, R. E., & Sørensen, S. (2024) · VBN Forskningsportal (Aalborg Universitet) · doi:10.6084/m9.figshare.26675222
Knudsen, J. K., Bundgaard‐Nielsen, C., Leutscher, P., Hjerrild, S., Nielsen, R. E., & Sørensen, S. (2024) · VBN Forskningsportal (Aalborg Universitet) · doi:10.6084/m9.figshare.26675219
Knudsen, J. K., Bundgaard‐Nielsen, C., Leutscher, P., Hjerrild, S., Nielsen, R. E., & Sørensen, S. (2024) · Figshare · doi:10.6084/m9.figshare.26675231
Knudsen, J. K., Bundgaard‐Nielsen, C., Leutscher, P., Hjerrild, S., Nielsen, R. E., & Sørensen, S. (2024) · VBN Forskningsportal (Aalborg Universitet) · doi:10.6084/m9.figshare.26675228
Knudsen, J. K., Bundgaard‐Nielsen, C., Leutscher, P., Hjerrild, S., Nielsen, R. E., & Sørensen, S. (2024) · VBN Forskningsportal (Aalborg Universitet) · doi:10.6084/m9.figshare.25124089
McCutcheon, T. B. (2025) · UNSWorks (UNSW Sydney) · doi:10.26190/unsworks/31693
de Faria, D. A., Perucci, L. O., Silva, Z. M., Pio, S., Talvani, A., & Barros-Pinheiro, M. (2026) · Scientific Reports · doi:10.1038/s41598-026-44447-y
“In vivo studies suggest that IL-10 may counteract depressive-like behaviors, as IL-10 knockout mice display increased helplessness – reversed by IL-10 administration – whereas IL-10 overexpression reduces depressive-like behavior 25 .”
Metadata
- Authors
- Roque, S., Correia-Neves, M., Mesquita, A. R., Palha, J. A., & Sousa, N.
- Affiliations
- University of Minho (PT)
- Life and Health Sciences Research Institute, School of Health Sciences, University of Minho, Campus Gualtar, 4710-057 Braga, Portugal
- Corresponding author
- Sousa, Nuno
- Venue
- Cardiovascular Psychiatry and Neurology
- Publisher
- Wiley
- Published
- 2009-08-16
- Volume
- 2009
- Pages
- 1-5
- ISSN
- 2090-0163 (ISSN-L)
- 2090-0171
- PMC
- PMC2775686
- OpenAlex
- W2074604677
- Cited by
- 89
- References
- 51
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 8 · 2023: 9 · 2022: 6 · 2021: 9 · 2020: 6 · 2019: 4 · 2018: 3 · 2017: 7 · 2016: 6 · 2015: 6 · 2014: 4 · 2013: 8 · 2012: 3
- FWCI
- 0.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Cardiovascular Psychiatry and Neurology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, other-oa)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, cc-by-nc-nd)
- Funders
- Fundação para a Ciência e a Tecnologia (SFRH/BD/24539/2005, PTDC/SAU-NEU/72699/2006)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- IL-10, depression, anti-inflammatory cytokines, inflammatory cytokines, hypothalamic-pituitary-adrenal axis, cytokine imbalance, depression-like behavior, antidepressant targets
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
